drugset / Trial / NCT00474812
Dasatinib in Treating Patients With Metastatic Pancreatic Cancer
NaSingle-groupOpen-labelTreatment
Summary
Dasatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. This phase II trial is studying how well dasatinib works in treating patients with metastatic pancreatic cancer.
Timeline
- Start
- 2007-05
- Primary completion
- 2013-01
- Completion
- 2014-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | dasatinib anhydrous | Small molecule | — | Oral |